| The effectiveness of risperidone in the treatment of three children with feeding disorders. | |
| | |
MedLine Citation:
|
PMID: 15662156 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Children with histories of extensive medical interventions in early childhood, especially those involving the gastrointestinal tract, are at-risk for residual feeding problems long after the medical issues have resolved. This case series describes the inpatient multidisciplinary treatment of 3 consecutive preadolescent children (ages 9, 8, and 7 years) admitted to our rehabilitation facility. Each child was admitted with a severe feeding disorder and histories of failure-to-thrive (FTT) that had required enteral nutritional interventions. Each child also had comorbid anxiety and mood symptoms. The addition of risperidone to behavioral and psychopharmacologic treatments was observed to significantly increase oral intake and accelerate weight gain. In 2 of 3 patients, assistive feeding interventions were successfully discontinued; and in a 3rd patient, enteral nutritional support was reduced by 74%. These cases suggest that risperidone may be a safe and effective adjunctive treatment, when behavioral feeding therapy is not sufficiently successful for children who have chronic and complicated medical and psychiatric presentations. |
| | |
Authors:
|
Paul Berger-Gross; Daniel J Coletti; Karen Hirschkorn; Elise Terranova; Edwin F Simpser |
Related Documents
:
|
10773906 - Tamil nadu nutritional survey comparing children aged 0-3 years with the nchs/cdc refer... 943936 - Sahel nutrition survey, 1974. 2929486 - Effects of missing breakfast on the cognitive functions of school children of differing... 19420226 - Description of a standardized nutrition classification plan and its relation to nutriti... 15819596 - Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potentia... 17387256 - Evolution and variability in fitness test performance of asian children and adolescents. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of child and adolescent psychopharmacology Volume: 14 ISSN: 1044-5463 ISO Abbreviation: J Child Adolesc Psychopharmacol Publication Date: 2004 |
Date Detail:
|
Created Date: 2005-01-21 Completed Date: 2005-05-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9105358 Medline TA: J Child Adolesc Psychopharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 621-7 Citation Subset: IM |
Affiliation:
|
Department of Medical Services, St. Mary's Healthcare System for Children, Bayside, New York 11360, USA. pbergwrgross@stmaryskids.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antipsychotic Agents
/
adverse effects,
therapeutic use* Anxiety Disorders / complications, drug therapy Child Child Behavior Disorders / complications, drug therapy Feeding and Eating Disorders of Childhood / complications, drug therapy* Female Humans Male Risperidone / adverse effects, therapeutic use* Weight Gain / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 106266-06-2/Risperidone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adolescent weight loss during treatment with olanzapine.
Next Document: Sedation for terminally ill patients with cancer with uncontrollable physical distress.